🕰️ On Your Own

While France keeps turning its boulevards into bonfires to defend the “constitutional right” to retire at 62, and Americans discover retirement right around the same time as the Last Rites, Switzerland quietly reinvented the concept two years ago. Since January 2024, anyone can retire between 63 and 70. The individual decides. Not the state. Not the unions. Not the angry collectives. The individual. Terrifying, right?

The Swiss miracle lies in something other countries pretend not to understand: a 65-year-old who’s mastered his job for four decades might actually be more useful than a 23-year-old who thinks PowerPoint is an energy drink. At Migros, the company contributes 17% to your pension while you only pay 8.5%. Coop does the same. Employers keep their talent and let them go when they decide. Elsewhere, companies fire people at 50 and then complain about “skills shortages.” Economic intelligence, Swiss edition.

The real genius is in how they handle “hardship.” No national commission, no universal grid, no endless parliamentary bickering. Every sector makes its own deal. Bricklayers in the Grisons can bow out at 60 under the FAR Foundation. Zurich bankers who love their Excel sheets can stay until 70. Airline pilots stop at 58, air-traffic controllers between 56 and 58, ballet dancers at 45. Each profession adjusts to its physical reality. What a revolutionary thought — adapting the rules to humans, not the other way around.

Of course, the system isn’t perfect. Between pension formulas, variable rates, and generational quirks, even the Swiss get lost in the math sometimes. But here’s the key difference: they accept complexity. They don’t pretend a single law can fit eight million situations. In most countries, we simplify everything — until it becomes monstrously unfair. In Switzerland, they complicate things just enough for everyone to find balance.

And the ultimate irony? The whole system costs less in policing than a single morning of traffic chaos on the Paris ring road. Companies retain their know-how, employees steer their own course, and the state saves money. Boring for 24-hour news channels, devastatingly efficient for public finances. While others keep reenacting the Paris Commune for the 21st century, the Swiss keep adjusting their social mechanics like a clockwork movement. Pragmatism never makes good television, but it keeps the pension funds full.

Have a good week,
M. Hantale 🧀

Want to get your brand in Helvetica? Drop us a line.

Diversify your assets in Switzerland
Find out why nearly 2 million Europeans already keep a Swiss account.

Top Stories

• 🇬🇧 Terrorism – Two people were killed and three injured in a knife attack outside a Manchester synagogue on Yom Kippur.
• 🇪🇬 Diplomacy – Israel and Hamas have begun indirect talks in Cairo under US mediation, exploring a possible ceasefire and a hostage-prisoner swap.
• 🇮🇱 Hostages – Netanyahu said he hopes to announce the release of 20 Israeli hostages held in Gaza “within days,” as part of a US-backed peace framework.
• 🇺🇸 Shutdown – The US government entered a full budgetary shutdown, furloughing 750K federal workers and closing key services — the first since 2018.
• 🇪🇺 Security – Major European airports including Munich, Oslo and Copenhagen have faced repeated disruptions from unidentified drones, likely of Russian origin.

Economy & Finance

• 🇪🇺 Savings – Brussels plans to redirect €1.2 trillion in private household savings over the next decade toward productive investment.
• 🇬🇧 Budget – The UK Chancellor is preparing tax hikes to fill a £50 billion fiscal gap, sparking renewed doubts about fiscal stability.
• 🇫🇷 Deficit – France projects a 5.4% budget deficit in 2025, as lawmakers warn of potential fiscal slippage.
• 🇫🇷 Inflation – French inflation picked up again late summer, mirroring similar trends in Spain and Belgium.
• 🇩🇪 Inflation – Germany’s annual inflation rate rose to 2.4% in September, breaking a months-long disinflation streak.
• 🇨🇭 Inflation – Swiss consumer prices rose just 0.2% year-on-year in September, confirming the country’s remarkable price stability.
• 🇺🇸 Employment – The US private sector unexpectedly cut 32K jobs in September, defying forecasts of 50K new positions.
• 🇨🇭 Entrepreneurship – In Switzerland, 37.5% of new businesses founded in 2024 came from foreign entrepreneurs — a record high.
• 🇨🇭 Central Bank – The SNB purchased CHF 5.1 billion in foreign currencies in Q2, sharply up from CHF 49 million the previous quarter.
• 🇺🇸 Gold – Gold prices climbed to $3,927 per ounce amid fears of a US government shutdown and renewed demand for safe havens.
• 🇨🇭 Instant Payments – The SNB and ECB are studying a direct link between their systems to enable near-instant cross-border payments between CHF and EUR.
• 🇨🇭 Refining – Swiss gold refiners are considering building a plant in the US to bypass new American import taxes and protect competitiveness.
• 🇺🇸 Shutdown Cost – A prolonged US shutdown is estimated to cost $15 billion per week and deprive analysts of key economic data.

Switzerland

• 🇨🇭 Defense – The US military has tasked Switzerland with disposing of its surplus munitions stored in Europe, deepening transatlantic defense ties.
• 🇨🇭 Defense Tech – The Swiss Army will invest CHF 108 million in a new system to detect mini-drones and protect critical infrastructure.
• 🇨🇭 Healthcare – 68% of Swiss citizens support the creation of a single national health insurance scheme to curb rising household premiums.
• 🇨🇭 Migration – Despite serving a record 12,700 beneficiaries, the Vaud asylum authority (EVAM) is cutting staff amid reduced public funding.
• 🇨🇭 Industrial Innovation – Switzerland inaugurated the world’s first two solar furnaces capable of recycling steel with zero CO₂ emissions.
• 🇨🇭 Urban Planning – A Zurich citizens’ initiative aims to make the city almost car-free, restricting vehicle use to essential cases only.
• 🇨🇭 Wind Energy – Two popular initiatives on wind farm development — focusing on forest protection and local democracy — will go to a national vote after collecting 100K+ signatures each.
• 🇸🇪 Nobel Watch – Two Swiss researchers are among the frontrunners for the 2024 Nobel Prizes in Medicine and Physics, alongside US, French, German, Japanese and Chinese candidates.
• 🇸🇪 Literature – Swiss author Christian Kracht is tipped by Swedish media as a leading contender for this year’s Nobel Prize in Literature.

Around the World

• 🇯🇵 Politics – Sanae Takaichi becomes the first woman to lead Japan’s Liberal Democratic Party and is set to become Prime Minister amid public distrust in the ruling party.
• 🇦🇷 Politics – Argentina’s Senate overturned President Javier Milei’s veto on higher university and hospital budgets, deepening a political crisis weeks before midterm elections.
• 🇨🇿 Elections – Billionaire and former PM Andrej Babiš won the Czech elections with 35.4% of the vote.
• 🇩🇪 Espionage – A former aide to an AfD MEP was sentenced to nearly five years in prison for passing information to Chinese intelligence.
• 🇨🇩 Justice – Former Congolese president Joseph Kabila was sentenced to death in absentia for treason and war crimes after a highly controversial trial.
• 🇫🇷 Justice – Halima Ben Ali, daughter of Tunisia’s former president, was placed under judicial supervision in Paris pending possible extradition for embezzlement.
• 🇲🇬 Protests – In Madagascar, Gen Z-led protests against the president entered their 10th day despite violent repression and multiple deaths.
• 🇲🇦 Protests – Morocco’s Gen Z 212 collective is calling for the government’s dissolution after several nights of unrest that left three dead.
• 🇦🇶 Climate – Antarctic winter sea ice reached its third-lowest extent in 47 years, confirming the accelerating pace of polar warming.

• 🇨🇭 Pharma – Roche and Novartis are ramping up their investments in the United States, anticipating trade tensions that could hit the pharmaceutical industry.
• 🇨🇭 Banking – UBS CEO Sergio Ermotti reaffirmed that the bank has “never considered leaving Switzerland,” dismissing persistent rumours about a potential relocation of its headquarters.
• 🇺🇸 Drug Pricing – Novartis plans to cut the US price of its blockbuster drug Cosentyx by half, anticipating possible sanctions from Donald Trump against major pharmaceutical firms.
• 🌍 Banking & Climate – The Net-Zero Banking Alliance, which once united 150 global banks around carbon neutrality targets, has officially disbanded amid mass departures and waning political support for climate action.
• 🇪🇺 Regulation – ECB President Christine Lagarde called for tighter oversight of hedge funds, private equity firms, and insurers, warning that these sectors still operate largely outside regulatory supervision.

Swiss Immunity

Same penalty, zero symptoms: pharma stays in perfect health.

So the verdict is in: starting October 1, the US will impose a 100 % tariff on “branded or patented” pharmaceutical products.

When Washington first announced 39 % duties on Swiss watches, precision tools and machinery, nobody really panicked. But this time feels different — pharma isn’t just another export niche. It’s the beating heart of the Swiss economy, accounting for roughly 8 % of GDP and driving export growth for decades.

And yet — wait for it — Trump added a tiny footnote:

“Unless the company builds its pharmaceutical factory in the United States.”

Now, who exactly exports the most drugs from Switzerland to the US?
Novartis, already pouring billions into new plants in Texas and Florida.
Roche, with vast research hubs and manufacturing capacity stateside.
Merck (Switzerland), following the same path.
And Lonza, the contract manufacturing giant that just acquired a new site in California.

If the exemption holds, these very firms — the ones that matter most — will barely feel a thing. The markets certainly got the memo: Roche and Novartis shares hardly moved after the tariff announcement.

So yes, you could argue Trump is getting exactly what he wanted: pushing Big Pharma to produce on American soil.
But for Switzerland, it’s less a loss than a change of geography.
Swiss-made exports may shrink, but US affiliates of Swiss groups will sell locally — and the profits will flow back home via intellectual property, R&D, and management still anchored in Basel and Zurich.

That’s the beauty of the pharma model: the real value sits upstream — in molecules, patents, and scientific know-how.
Unlike carmakers, where factories define value, or tech hardware, where assembly is king, pharma’s wealth lives in the chemistry, not the packaging.

In practice, Swiss exports might decline, but the income balance stays positive: profits, royalties, and licensing revenues keep pouring into the country, supporting the franc and the trade surplus.

As long as the “command room” of global pharma remains in Switzerland, there’s no reason to panic. The symptoms may be American, but the immune system is unmistakably Swiss.

— Quentin de Gryse

Want to get your brand in Helvetica? Drop us a line.

Diversify your assets in Switzerland
Find out why nearly 2 million Europeans already keep a Swiss account.